Spin Echo (SE) and Turbo Spin Echo (TSE/FSE) — Physics, Parameters, and Clinical Applications
MRIninja Knowledge Base | Sequence Child Page Parent page: 9003-mri-sequences-overview-classification Version 1.0 — May 2026
1. Introduction: Historical Evolution and Clinical Purpose
The spin echo is the foundational signal acquisition paradigm of clinical MRI, and the turbo spin echo (TSE) — its multi-echo derivative — is the single most widely used sequence family in modern clinical practice. Together they underpin the majority of anatomical T1, T2, and PD-weighted imaging across virtually every body region and at every clinical field strength in routine use.
The spin echo was discovered by Erwin Hahn in 1950 [14], who observed that after a radiofrequency pulse tilted nuclear spins away from equilibrium, a second RF pulse applied at a specific later time could reverse the dephasing of transverse magnetisation and produce a coherent signal — the echo — even after the free induction decay had apparently disappeared. This phenomenon was not incidental: it allowed signal recovery after the irreversible effects of static field inhomogeneity had seemingly destroyed the transverse coherence. In Hahn's formulation, both the excitation and the refocusing pulses were 90° pulses; the 90°–180° variant, which became the clinical standard, was introduced by Carr and Purcell [15] and later refined by Meiboom and Gill, whose phase correction gave rise to the Carr-Purcell-Meiboom-Gill (CPMG) sequence — the direct ancestor of all clinical multi-echo TSE sequences.
The clinical MRI era began at 1.5T where the long T1 relaxation times required long TR values for T2-weighted imaging. Conventional spin echo with a single 90°–180° pair per TR was diagnostically adequate but time-inefficient: a 256-phase-encode T2-weighted brain acquisition required 20–40 minutes. Jürgen Hennig's 1986 introduction of RARE (Rapid Acquisition with Relaxation Enhancement) [1] — now universally known as Turbo Spin Echo (TSE; Siemens, Philips) or Fast Spin Echo (FSE; GE) — solved this problem by applying multiple refocusing pulses in a single TR, filling multiple k-space lines per excitation. An ETL of 16 reduced a 20-minute T2 scan to under 2 minutes, enabling clinical brain MRI within a tolerable examination time. This single advance transformed neuroradiology, body MRI, and musculoskeletal imaging.
The SE family was designed to solve three clinical problems that gradient echo sequences could not adequately address: (1) reliable T2-weighted contrast without T2 contamination from local field inhomogeneities; (2) robust imaging near metallic implants and at air-tissue interfaces where B0 is heterogeneous; and (3) reproducible quantitative tissue characterisation based on intrinsic T1 and T2 relaxation rather than susceptibility-dependent T2.
Today, conventional SE is rarely used in clinical practice — its time inefficiency is unacceptable. TSE/FSE is the universal clinical standard. However, the physics of the 90°–180° pair remains the foundation from which all SE-family sequences derive.
2. Physical Foundations
2.1 Pulse Sequence Logic and Signal Formation
A spin echo sequence consists of a 90° radiofrequency (RF) excitation pulse followed at a time TE/2 by a 180° RF refocusing pulse. The resulting echo is centred at time TE after the initial excitation.
The 90° excitation pulse tips the longitudinal magnetisation vector (Mz) into the transverse plane (Mxy), creating maximum transverse magnetisation. Immediately after the 90° pulse, all spin isochromats are approximately in phase. They then precess at slightly different frequencies due to local B0 field differences (T2 dephasing) and intrinsic spin-spin interactions (T2 decay). The macroscopic transverse magnetisation decays as a free induction decay (FID) at the rate 1/T2, which is faster than the intrinsic 1/T2.
The 180° refocusing pulse applied at time TE/2 inverts the phase of all transverse magnetisation components. Faster-precessing isochromats, which have accumulated the most phase advance, are now behind the slower ones. As time proceeds, the faster isochromats catch up to the slower ones: at time TE after the initial 90° pulse, all isochromats that have been dephased by static B0 inhomogeneities come back into phase simultaneously, producing the spin echo.
The critical distinction from gradient echo: the 180° refocusing pulse eliminates all dephasing from static field inhomogeneities (local B0 variations from tissue susceptibility, metal, air-tissue interfaces), which are refocused symmetrically. What the 180° pulse cannot refocus is the irreversible T2 decay from spin-spin (dipole-dipole) interactions, because these are stochastic and not phase-reversible. Therefore, the spin echo signal amplitude at time TE is:
S(TE) = M₀ · (1 − e^(−TR/T1)) · e^(−TE/T2)
The first term reflects T1 recovery during the TR interval; the second reflects true T2 decay by TE. The T2* dephasing is eliminated by the 180° pulse and does not contribute to echo amplitude.
Contrast Determinants
T1 weighting is achieved by using a short TR (< T1 of the tissues of interest), so that tissues differ in how much longitudinal magnetisation they have recovered before the next 90° pulse. Tissues with short T1 (fat, white matter) recover more fully than tissues with long T1 (CSF, oedema), generating T1 contrast.
T2 weighting is achieved by using a long TE, allowing tissues with different T2 values to produce different signal amplitudes at the echo time. Tissues with long T2 (CSF, free fluid) retain more transverse magnetisation at TE than tissues with short T2 (muscle, tendons), generating T2 contrast.
PD weighting is achieved by minimising both T1 and T2 contrast: long TR (eliminating T1 difference) and short TE (minimising T2 decay before readout).
Turbo Spin Echo (TSE/FSE)
In TSE, the 90° excitation is followed not by a single 180° but by an echo train of N successive 180° pulses, each separated by a constant echo spacing (ES). Each echo in the train is phase-encoded differently and fills a separate line of k-space. The number of echoes per TR is the echo train length (ETL) or turbo factor. The acquisition time is reduced by a factor of ETL compared to conventional SE.
The effective TE is the echo time of the echo(es) that fill the centre of k-space (low spatial frequencies, which determine image contrast). The position of the effective TE within the echo train can be centric (early echoes fill the k-space centre, producing short effective TE and T1/PD contrast) or linear (later echoes fill the centre, producing long effective TE and T2 contrast).
The primary artefact consequence of TSE is T2 blurring: echoes acquired later in the train have experienced more T2 decay than early echoes, resulting in a different signal amplitude for each k-space line. When high spatial frequencies are filled by late (heavily T2-decayed) echoes, fine structural details (edges, thin structures) appear blurred. This blurring is proportional to ETL and T2 relaxation rate; structures with very short T2 (tendons, ligaments, cortical bone) are most severely affected. Reducing ETL or using view-ordering strategies (amplitude-modulated k-space filling) mitigates blurring.
2.2 Pulse Sequence Logic and Signal Formation: Complete pulse diagram with white background and official palette.
Five channels: RF — 90° in teal (sync with sidelobes) and 180° in gold (higher, same shape), with labels Gz (slice selection) — teal trapezoid below 90° with the negative rephasing lobe, and gold trapezoid below 180° Gx (frequency encoding) — negative pre-phaser lobe and readout trapezoid centered on the echo Gy (phase encoding) — a representative Δφ lobe plus the dashed rewind after readout Signal — small FID decaying after 90°, then the Gaussian echo centered at TE with teal fill and dot on the peak Timing annotations:
TE/2 in gold between 90°–180° and between 180°–echo peak TE in black between 90° and echo peak TR in black for the entire period Vertical dashed lines for visually align the three critical events
3. Key Parameters and Their Clinical Meaning
3.1 Parameter Table
| Parameter | Effect on Contrast | Effect on Image Quality | Practical Notes (1.5T / 3T) |
|---|---|---|---|
| TR (repetition time) | Primary T1 determinant: short TR → T1-weighted; long TR → T2/PD-weighted | Long TR → higher SNR from full recovery; increases scan time | T1: 400–700ms / 550–800ms; T2: 2500–5000ms / 2500–4500ms; PD: ≥2500ms |
| TE (echo time) | Primary T2 determinant: short TE → T1/PD-weighted; long TE → T2-weighted | Long TE → lower SNR (exponential T2 decay) | T1: 10–20ms; PD: 20–35ms; T2: 80–120ms; ETL-dependent |
| ETL (turbo factor) | Affects effective TE and T2 blurring | High ETL → faster scan, more blurring; Low ETL → slower, sharper | T1/PD: 2–8; T2 brain: 10–20; T2 spine: 8–16; MSK PD: 6–12 |
| Flip angle (FA) of refocusing pulses | Variable FA (SPACE/CUBE) extends ETL without excessive SAR; fixed 180° maximises signal | Variable FA → slightly lower SNR per echo but enables 3D long ETL | Fixed 180° standard for 2D; variable FA mandatory for 3D TSE at 3T |
| Bandwidth (BW) | Minimal effect on contrast | Wide BW → less chemical shift artefact, less geometric distortion, lower SNR | 130–200 Hz/px (1.5T); 200–400 Hz/px (3T) to control CS artefact |
| Slice thickness | Minimal | Thinner → less partial volume, lower SNR; thicker → more PV | 3–5mm standard; 1–3mm for MSK; 1mm isotropic for 3D |
| FOV | None | Smaller FOV → higher resolution, more aliasing risk; larger → lower resolution | 200–360mm brain/spine; 100–180mm MSK; 150–200mm pelvis |
| In-plane resolution | None | Higher resolution → lower SNR, longer scan; reduced for motion | ≤0.5×0.5mm MSK; ≤0.8×0.8mm spine T2; ≤0.4×0.4mm wrist |
| Echo spacing (ES) | Affects T2 blurring: short ES → less blurring | Short ES → shorter acquisition window per TR → may need higher BW | 8–12ms typical; shorter with higher BW |
| Fat suppression | Transforms PD-FS/T2-FS appearance | STIR robust; SPAIR B0-dependent; Dixon most flexible | STIR post-Gd contraindicated; Dixon preferred off-isocentre |
| Number of averages (NSA/NEX) | None | Higher NSA → higher SNR, longer scan time; √NSA relationship | 1–2 standard; 2–4 for small structures; 1 with parallel imaging |
| Partial Fourier | None directly | Reduces scan time; minor phase errors; Gibbs ringing risk | 5/8 or 6/8 typical; avoid < 5/8 for high-resolution |
Parameter Interdependence Notes
At 3T, tissue T1 values are systematically longer than at 1.5T (WM T1: ~800ms at 1.5T → ~1100ms at 3T; GM: ~900ms → ~1300ms; fat: ~250ms → ~380ms), requiring TR adjustments for equivalent T1 contrast. SAR is 4-fold higher at 3T for the same flip angle and TR, requiring TR extension or flip angle reduction for long-ETL TSE sequences.
3.2 Parameter Table
aggiungere i 4 diagrammi allegati in html
SE — T1-weighted magnetisation diagram at 1.5T
Open fullscreenSE — T1-weighted magnetisation diagram at 3T
Open fullscreenSE — T2-weighted magnetisation diagram at 1.5T
Open fullscreenSE — T2-weighted magnetisation diagram at 3T
Open fullscreen4. Tissue Contrast Profiles
| Tissue | T1-weighted SE (short TR, short TE) | T2-weighted SE (long TR, long TE) | PD-weighted SE (long TR, short TE) | Common Pathological Variations |
|---|---|---|---|---|
| White matter | Bright (short T1 ~830ms at 3T) | Intermediate-low (T2 ~80ms) | Intermediate | Demyelination: T2 bright, T1 intermediate; gliosis: T2 bright |
| Grey matter | Intermediate (T1 ~1300ms at 3T) | Intermediate (T2 ~90ms) | Bright | Iron: T2 dark (deep GM); oedema: T2 bright |
| CSF / free fluid | Dark (very long T1 ~4000ms) | Very bright (very long T2 ~1900ms) | Very bright | Proteinaceous CSF: T1 brighter, T2 slightly lower |
| Fat | Bright (very short T1 ~380ms at 3T) | Intermediate (T2 ~68ms) | Bright | Lipoma: T1 bright, fat-sat suppressed; necrosis: T2 bright |
| Muscle | Intermediate-low (T1 ~1400ms at 3T) | Intermediate-low (T2 ~50ms) | Intermediate | Oedema/myositis: T2 bright; fibrosis: T2 dark; denervation: T2 bright |
| Hyaline cartilage | Dark-intermediate | Bright-intermediate (T2 ~40ms) | Bright | Chondral defect: T2 focal loss; degeneration: T2 inhomogeneous |
| Tendon/ligament | Very dark (T2* ~1ms; T2 ~2ms) | Very dark; magic angle signal at 55° | Dark | Tear: T2 bright gap; tendinopathy: T2 diffuse signal |
| Cortical bone | Signal void | Signal void | Signal void | Stress fracture: STIR bright periosteal oedema |
| Bone marrow (yellow) | Bright (fat-like T1) | Intermediate | Bright | Replacement by tumour/oedema: T1 dark, STIR/T2 bright |
| Oedema / tumour | Dark (long T1) | Bright (long T2) | Bright | Generally: T1 dark, T2 bright; haemorrhage variable by stage |
| Subacute haematoma | Very bright (MetHb T1 shortening) | Variable by stage | Bright | DeoxyHb: T2 dark; MetHb: T1 bright; haemosiderin: T2 very dark |
| Gadolinium enhancement | Bright (T1 shortening) | Minimal effect | Minimal effect | Breakdown of BBB or vessel permeability; early: bright; late: persists |
Interpretation Pitfalls
Magic angle artefact: tendons and ligaments oriented at approximately 55° to B0 show spurious T1 and PD signal elevation due to dipole-dipole orientation effects. Occurs on sequences with TE < 40ms. Verification: signal disappears at TE > 60ms (T2-weighted sequence).
T2 shine-through on PD-FS: structures with very long T2 retain high signal on PD-weighted images despite minimal true restriction — most commonly cysts, ganglia, and CSF spaces. Confirm true tissue characterisation on T1 (CSF/fluid is dark on T1).
TSE T2 blurring of cartilage: long ETL on MSK TSE blurs the thin cartilage layers. ETL must be ≤ 8–10 for cartilage assessment to prevent diagnostic quality reduction.
5. Vendor Implementations
| Manufacturer | Conventional SE | Turbo/Fast SE | 3D TSE (Variable FA) | Single-Shot TSE |
|---|---|---|---|---|
| Siemens | SE | TSE | SPACE | HASTE |
| GE | SE | FSE | CUBE | SSFSE |
| Philips | SE | TSE | VISTA | SSTSE |
| Canon | SE | FSE | isoFSE | FASE |
| Hitachi | SE | FSE | isoFSE | FASE |
Implementation Differences
Refocusing pulse profile: Siemens and Philips use a time-bandwidth product (TBW) factor of 4–8 for the 180° refocusing pulse slice profile. Higher TBW produces sharper slice profiles at the cost of higher RF power (SAR). At 3T, Siemens SPACE and Philips VISTA both use variable flip angle (VFA) trains that maintain steady-state magnetisation through a blend of stimulated and refocused echoes — the exact VFA schedule (T1-weighted, T2-weighted, or intermediate) is vendor-specific and produces slightly different contrast at identical nominal parameters.
Echo train design: GE CUBE uses a specific VFA train that tends to produce slightly sharper edge definition than Siemens SPACE at equivalent resolution, due to differences in the apodisation applied to k-space. Philips VISTA provides the most direct user control over the VFA train design through the T1/T2 contrast mode selector.
k-space ordering: Siemens TSE uses sequential linear ordering by default; GE uses sequential with amplitude-modulated k-space reordering for FSE; Philips offers several modes. Centric k-space ordering places early-TE (highest SNR) echoes at the k-space centre, improving effective TE accuracy but potentially increasing Gibbs ringing for structures with sharp edges.
SAR management at 3T: all vendors implement automatic TR extension or SAR monitoring when the refocusing pulse train would exceed IEC safety limits. The SAR per refocusing pulse is proportional to FA². Variable FA trains (SPACE/CUBE/VISTA) use lower-flip-angle echoes in the outer echo train, reducing SAR while maintaining SNR through steady-state magnetisation pathways.
6. Clinical Applications Overview
| Clinical Application | Anatomical Region | Primary Use | Alternative Sequences |
|---|---|---|---|
| T1 anatomy | Brain, spine, body (all regions) | Anatomical delineation, gadolinium enhancement | MPRAGE (3D isotropic), VIBE (body) |
| T2 lesion detection | Brain (tumour, MS, stroke) | Primary lesion sensitivity sequence | FLAIR (periventricular), 3D FLAIR |
| T2 spine | Cervical, thoracic, lumbar spine | Cord and disc pathology | 2D sagittal TSE standard; sagittal STIR for bone marrow |
| PD-FS MSK | Shoulder, knee, hip, elbow, ankle | Rotator cuff, meniscus, ligament | GRE-based (T2*), 3D TSE isotropic |
| T2 pelvis | Uterus, prostate, rectum, bladder | Zonal anatomy, staging | 3D TSE (SPACE/CUBE/VISTA) |
| T2 liver/pancreas | Abdomen | Bile duct anatomy, cyst characterisation | MRCP (HASTE, RARE), T2 FS-TSE |
| MRCP | Biliary system | Ductal morphology | Single-shot RARE, navigator-gated TSE |
| T2 breast | Breast | Background parenchymal enhancement, cyst vs solid | T1 DCE |
| T2 orbit | Orbits, extraocular muscles | Inflammatory orbitopathy, mass | STIR (fat suppressed) |
| T2 cardiac | Heart | Myocardial oedema (modified LGE protocol) | STIR-b-SSFP, T2 mapping |
| MR myelography | Spine | CSF space, cauda equina | HASTE/SSFSE thick slab |
| Inner ear | Temporal bone | Cochlea, labyrinth morphology | 3D SPACE/CISS |
| Vessel wall imaging | Intracranial vessels | Wall enhancement, dissection | 3D TSE DANTE/MSDE prepared |
When SE/TSE is Preferred Over Alternatives
Near metallic implants: the 180° refocusing pulse of TSE suppresses susceptibility artefacts from implants (hip prosthesis, spinal hardware) far more effectively than any GRE sequence. TSE with wide bandwidth and STIR fat suppression is the approach of choice for MARS (Metal Artefact Reduction Sequences) protocols.
Posterior fossa brain imaging: EPI-based sequences (DWI, fMRI) suffer from severe distortion and signal dropout at the posterior fossa due to susceptibility artefacts from the petrous bone, mastoid air cells, and skull base. TSE T2 provides artefact-free posterior fossa imaging.
Cartilage and ligament assessment at MSK: PD-FS TSE with appropriate ETL (6–12) and in-plane resolution (0.3–0.5mm) provides the tissue contrast required for fibrocartilage and articular cartilage assessment that no other clinical sequence reliably matches.
T2-weighted body (non-breath-hold): respiratory-triggered TSE outperforms GRE for abdominal T2 imaging when breath-holding is not possible, because TSE is more compatible with cardiac and respiratory navigator triggering.
7. Artefacts
| Artefact | Physical Cause | Image Appearance | Potential Mimic | Reduction Strategies |
|---|---|---|---|---|
| Gibbs ringing (truncation) | Finite k-space sampling; sharp high-contrast edges | Parallel lines at high-contrast interfaces (brain-CSF, spine-CSF) | Periventricular lesions; syrinx | Increase phase matrix; zero-fill interpolation; Hanning filter |
| Chemical shift (type 1) | Different resonant frequencies of water and fat in frequency direction | Bright and dark bands at fat-water interfaces in FE direction | Lesion at interface | Increase BW; fat suppression |
| T2 blurring (TSE) | Progressive T2 decay across the echo train | Blurring of fine structures, especially short-T2 (cartilage, tendons) | Partial volume; reduced resolution | Reduce ETL; adjust effective TE; use short ETL for MSK |
| Magic angle artefact | Orientation-dependent dipole-dipole relaxation at 55° to B0 | T1/PD signal elevation in tendon at 55° to B0 | Tendinopathy; partial tear | Longer TE (T2-weighted); patient repositioning; clinical correlation |
| Motion artefact (phase ghosting) | Patient or physiological motion in phase direction during TR | Ghosting in phase direction | Pathological lesions in motion path | Respiratory triggering; cardiac gating; saturation bands; NSA increase |
| Flow artefact (even-echo rephasing) | Even-echo refocusing of flowing spins | CSF or blood bright signal on even echoes | Lesion within vessel; CSF pathology | Flow saturation bands; choose odd-echo images; cardiac gating |
| Cross-talk / cross-excitation | Imperfect slice profile from adjacent slices sharing excitation | Signal reduction in adjacent slices; T1 contamination | Lesions at slice boundaries | Interleaved acquisition; slice gap (10–30%); multi-slab |
| Dielectric effect (3T) | B1+ inhomogeneity at 3T produces signal centre-brightening (high conductivity tissues) | Signal bright in central abdomen/pelvis at 3T | Pathological enhancement | Dielectric pads; adiabatic pulses; parallel transmit (vendor-specific) |
| SAR-related TR extension (3T TSE) | Automatic TR extension by scanner to comply with SAR limits | Reduced T1 contrast; apparent brightening of long-T1 tissues | Changes in expected contrast | Reduce ETL; reduce flip angle; use variable FA |
| Stimulated echo contamination | Multiple pathways in long echo trains produce stimulated echoes with mixed T1/T2 weighting | Unexpected signal from short-T1 tissues (fat) at long TE | Fat signal outside expected distribution | Crusher gradients; CPMG phase cycling; short ES |
8. Advanced Technical Parameters
Echo Train Length (ETL) and k-Space Filling Strategies
The ETL is the primary determinant of TSE acquisition efficiency and image quality trade-off. The k-space filling order determines which echoes sample which spatial frequencies:
Linear ordering: echoes are acquired in sequential phase-encode order from high negative to high positive spatial frequency. The effective TE corresponds to the echo that fills k=0. Consistent with predictable T2 weighting but susceptible to T2 modulation across k-space.
Centric ordering: the first echo (shortest TE, highest amplitude) fills k=0 (image centre). Subsequent echoes fill outward. Produces T1/PD-like contrast regardless of nominal TE; optimal for short-T2 tissues and contrast-enhanced imaging where early gadolinium enhancement should dominate contrast.
Amplitude-modulated (RASER/SPACE reordering): k-space lines are filled in an order that minimises signal amplitude modulation across k-space, reducing T2 blurring for long-ETL 3D TSE acquisitions. This is the default ordering in SPACE/CUBE/VISTA and is the reason 3D TSE produces less blurring than simple sequential ordering would predict at equivalent ETL.
Bandwidth
Receiver bandwidth (Hz/pixel) determines: (1) the frequency range sampled during the readout window; (2) acquisition time per echo (readout time = 1/BW × matrix); (3) chemical shift displacement in the frequency-encoding direction. Higher BW: shorter readout → less T2* decay during readout → sharper edges at long TE; less chemical shift artefact; lower SNR (noise proportional to √BW). At 3T, higher BW is required to maintain chemical shift artefact below clinical thresholds.
Parallel Imaging in TSE
GRAPPA (Siemens), ASSET (GE), SENSE (Philips), and SPEEDER (Canon) reduce acquisition time by undersampling k-space in the phase direction by a factor R (typically R=2–4) and reconstructing the missing lines using coil sensitivity maps. For TSE, parallel imaging reduces scan time without affecting ETL or T2 blurring profile. SNR penalty: proportional to √R × g-factor (g > 1 for non-optimal coil geometry). R=2 is the standard clinical balance; R=3–4 is used with large channel-count coils (≥16 channels) at 3T where the g-factor penalty remains acceptable.
2D versus 3D TSE
2D TSE (standard): slices acquired independently; inter-slice gap required (typically 0–20%) to reduce cross-excitation; slice thickness ≥ 2mm practical; in-plane resolution independent of through-plane; most motion-robust; shorter per-sequence acquisition time.
3D TSE (SPACE/CUBE/VISTA): isotropic voxels; no inter-slice gap; full MPR capability; SNR higher per unit time than 2D; acquisition time 6–12 minutes; more motion-sensitive (all k-space corrupted by any motion); ETL typically 100–300 echoes using VFA to manage SAR and T2 blurring; mandatory at 3T for pelvic staging, inner ear, vessel wall imaging, and dedicated joint cartilage assessment.
SAR Considerations (3T TSE)
SAR (Specific Absorption Rate) for a TSE sequence scales as: SAR ∝ FA² × N_echoes / TR. At 3T, SAR is approximately 4× higher than at 1.5T for identical sequence parameters. Long-ETL TSE at 3T with 180° refocusing pulses regularly exceeds IEC first-level SAR limits, requiring automatic TR extension by the scanner. Practical implications:
- T1-weighted TSE at 3T: TR is frequently auto-extended from the nominal 600ms to 700–900ms, reducing T1 contrast. Users should increase flip angle reduction or use variable FA TSE.
- T2-weighted TSE at 3T: long TR (> 3000ms) provides more TR budget for SAR; ETL can typically be maintained without auto-extension.
- 3D TSE at 3T: VFA is mandatory to keep SAR within limits; SPACE/CUBE/VISTA implement this automatically.
AI Reconstruction and Deep Learning in TSE
All major vendors now offer DLR (Deep Learning Reconstruction) for TSE sequences: Siemens Deep Resolve Boost, GE AIR Recon DL, Philips SmartSpeed, Canon AiCE. These denoise images from undersampled acquisitions (2–4× acceleration) to produce diagnostic quality equivalent to or exceeding fully sampled images. Published validation data for brain, spine, knee, and pelvic TSE sequences demonstrate maintained or improved SNR and CNR with reduced acquisition time [5, 6]. DLR enables: 2–4× time reduction; higher resolution within the same time; or equivalent quality at lower field strength. Not yet validated for all clinical applications — research-context caution applies.
Dixon Fat Suppression in TSE
Dixon fat suppression in TSE exploits the chemical shift between water and fat protons (3.5 ppm; 220 Hz at 1.5T; 440 Hz at 3T) by acquiring echoes at specific TE values where water and fat are in-phase (IP) and out-of-phase (OP). Combined with TSE readout, Dixon provides: (1) B0-independent fat-water separation; (2) simultaneous fat-only and water-only images; (3) fat fraction quantification. The mDixon implementation (Philips) and IDEAL (GE) are the primary clinical tools. Dixon is the preferred fat suppression strategy for off-isocentre TSE (elbow, wrist, ankle, finger) where CHESS/ChemSat fails.
9. Comparison with Alternative Sequences
| Clinical Need | SE/TSE | GRE/SPGR | EPI (SE/GRE) | bSSFP | Comment |
|---|---|---|---|---|---|
| T2-weighted brain | ✓✓ Gold standard | ✗ T2* not T2; susceptibility | ✗ Distortion, dropout | ✗ Banding artefacts | TSE preferred |
| T2-weighted posterior fossa | ✓✓ | ✗ Susceptibility dropout | ✗ Severe dropout | ✗ | TSE only reliable option |
| T1 brain anatomy | ✓ (2D) | ✓✓ MPRAGE (3D isotropic) | ✗ | ✗ | MPRAGE preferred for 3D; TSE for 2D |
| Near metallic implants | ✓✓ MARS-TSE | ✗ Severe susceptibility | ✗ | ✗ Banding | TSE with STIR; wide BW |
| Fast whole brain (DWI) | ✗ Too slow | ✗ | ✓✓ SE-EPI | ✗ | EPI only practical option |
| Dynamic contrast (DCE) | ✗ Too slow | ✓✓ VIBE/LAVA/THRIVE | ✓ GRE-EPI | ✗ | Spoiled GRE preferred |
| Cardiac function | ✗ | ✗ | ✓ GRE-EPI | ✓✓ cine bSSFP | bSSFP gold standard |
| MSK cartilage | ✓✓ PD-FS TSE | ✓ T2*-GRE | ✗ | ✗ | TSE preferred for clinical |
| Vascular bright-blood | ✗ | ✓✓ GRE-TOF/CE-MRA | ✗ | ✓✓ | GRE/CE-MRA or bSSFP |
| Perfusion | ✗ | ✓✓ DCE-GRE | ✓✓ DSC-EPI | ✗ | EPI/GRE preferred |
10. Evidence Gaps and Ongoing Debate
Optimal ETL for MSK PD-FS at 3T: no consensus guideline defines the maximum acceptable ETL for diagnostic-quality knee or shoulder MRI. Published series use ETL ranging from 6 to 20 for PD-FS at 3T. A systematic comparison with arthroscopy or histopathology as reference standard is lacking. Expert consensus generally recommends ETL ≤ 10–12 for rotator cuff and ≤ 8 for menisci, but this is not evidence-based.
3D TSE vs 2D TSE for prostate staging T2: PI-RADS v2.1 specifies 2D axial TSE as the primary prostate T2 sequence, despite 3D TSE providing isotropic reformats. Published comparison studies show comparable diagnostic accuracy for dominant lesion characterisation but data on ECE grading and seminal vesicle assessment are limited.
VFA train design (SPACE vs CUBE vs VISTA): the different VFA schedules implemented by the three major 3D TSE platforms produce slightly different tissue contrast profiles, particularly at tissue interfaces. No prospective multicentre comparison has established superiority for specific clinical applications.
DLR validation scope: deep learning reconstruction for TSE has been validated in large single-vendor studies but multivendor, multicentre prospective validation for specific diagnostic tasks (small lesion detection, cartilage grading) is not complete. False-positive smoothing artefacts from some DLR implementations in small lesion detection remain a theoretical concern.
STIR vs Dixon vs SPAIR for body MRI: no high-quality head-to-head randomised trial exists comparing these fat suppression strategies for diagnostic accuracy across body MRI applications. Departmental practice is primarily vendor-dependent and tradition-based.
11. Miscellaneous and Related Topics
Driven Equilibrium TSE (DRIVE / RESTORE / FRFSE)
A variant in which a final 90° pulse at the end of the echo train flips residual transverse magnetisation back to the longitudinal axis, accelerating T1 recovery. This allows shorter TR without significant T1 contrast penalty, reducing acquisition time while maintaining fluid-bright contrast. Particularly useful for MR myelography (bright CSF), inner ear imaging, and CSF-space imaging.
Magnetisation Transfer Contrast (MTC) in TSE
Off-resonance RF pulses applied before TSE excitation can saturate the bound proton pool (macromolecular protons in myelin, protein), reducing the free-water signal in proportion to macromolecular content. MTC improves GM-WM contrast in the brain and provides additional tissue characterisation information. Rarely used in routine practice due to SAR concerns at 3T and available simpler alternatives.
Half-Fourier TSE (HASTE/SSFSE/FASE)
The extreme ETL case: the entire k-space is acquired in a single shot (TR = ∞ effective). Acquisition time per slice is approximately 100–300ms — immune to respiratory and most cardiac motion. Used for abdominal T2 screening, fetal MRI, MRCP, and myelography. Contrast is heavily T2-weighted (very long effective TE from the single shot). The single-shot constraint inherently limits resolution and produces some T2 blurring — acceptable for the clinical applications where HASTE is used.
Emerging Research Applications
MR fingerprinting (MRF): uses a pseudo-random TR/TE sequence and pattern recognition to simultaneously quantify T1, T2, and proton density maps in a single acquisition. TSE-based MRF variants are in early clinical validation and may eventually replace multi-contrast conventional SE protocols with a single quantitative acquisition.
Quantitative T2 mapping: multi-echo TSE at multiple TE values provides T2 maps. Standard in cartilage assessment research (T2 map reflects cartilage matrix integrity); increasingly used for myocardial T2 (oedema), liver fibrosis staging, and multiple sclerosis research. Not yet sufficiently standardised for routine clinical reporting.
12. Bibliography
A. Guidelines / Consensus / Society Recommendations
(No society guideline is specifically dedicated to SE/TSE sequence design. The ACR, ESUR, and MAGNIMS recommendations reference TSE as the standard modality within specific anatomical protocol guidelines — see the relevant anatomical protocol pages.)
B. Systematic Reviews / Meta-analyses
C. Important Prospective / Original Studies
D. Technical MRI Papers
E. Landmark Historical References
End of text document — SE Spin Echo / TSE — MRIninja Sequence Page v1.0 — May 2026 Interactive pulse diagram and magnetisation curve diagrams are rendered as separate widgets on the MRIninja page.
Related Protocols
Recent PubMed search for this protocol